Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could pursue a new ...

Reckitt said on Friday a circuit court in the United States had ruled that a new trial could be sought by plaintiffs in a ...

Abbott Laboratories and Reckitt Benckiser Group Plc shares fell as a judge ordered a new trial after rejecting a verdict that ...

Back in October, a jury found North Chicago-based Abbott and Reckitt’s formula subsidiary Mead Johnson not responsible for a ...

Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in their ...

Abbott was down 2.7% at 1:54 p.m. in New York after paring morning losses, while Reckitt’s shares fell as much as 5.6% in London before closing down 1.7%. Both early declines were the biggest in ...

The ruling overturned a previous verdict related to an infant formula case and has implications for both Abbott and Reckitt, ...

Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.

Citi notes that Investing.com reported on Friday that the judge in the Whitfield infant formula case has overturned the October 31 verdict, ...